Viking Therapeutics Appoints Dr. Hubert Chen as Chief Medical Officer
Viking Therapeutics announced the appointment of Hubert Chen, M.D., as chief medical officer. Dr. Chen brings more than two decades of leadership experience in senior executive roles spanning drug discovery, clinical development, regulatory strategy, and product approvals across multiple therapeutic areas. Dr. Chen will report to Brian Lian, Ph.D., president and chief executive officer of Viking Therapeutics, and oversee clinical development, medical, and regulatory affairs.
